Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Device Detects Malaria in Simple Blood Test

By LabMedica International staff writers
Posted on 18 May 2011
A diagnostic screening device, which separates malaria-infected red blood cells from uninfected red blood cells by way of magnetic levitation has been developed. More...


The prototype system requires less than a drop of finger-prick blood and a small volume of erythrocyte isotonic buffer containing paramagnetic ions and is lightweight, disposable, and inexpensive to manufacture.

Scientists at the Beth Israel Deaconess Medical Center (BIDMC; Boston, MA, USA) used the principles of magnetic levitation and cell phone technology to create an inexpensive, portable device to diagnose malaria quickly and accurately outside of the routine laboratory setting. The device uses a set of permanent magnets immobilized in a plastic structure surrounding a glass or plastic capillary containing the blood. Results are visualized, recorded and stored using a standard camera phone and no additional imaging equipment or staining reagents are required.

Ionita Ghiran, MD, an investigator at BIDMC and an assistant professor of medicine at Harvard Medical School (Boston, MA, USA) has been awarded a $100,000 grant from the Bill & Melinda Gates Foundation (Seattle WA, USA), for the development of the device. Professor Ghiran said, "The lack of suitable methods of malaria diagnosis makes presumptive treatment often the only available option for local health service providers. This method helps fill the need for malarial diagnostic technologies capable of promptly and reliably ascertaining true malarial infections in the field. We hope that this will help prevent the over diagnosis of malaria and subsequent drug resistance."

An estimated 200 to 500 million cases of malaria occur each year with 50% to 90% of these in Africa. Malaria causes nearly one million deaths per year throughout developing countries, 85% of whom are children under the age of five, and parasites are becoming increasingly resistant to antimalarial drugs, in part due to misdiagnosis.

Related Links:
Beth Israel Deaconess Medical Center
Harvard Medical School
Bill & Melinda Gates Foundation




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Blood Glucose Test Strip
AutoSense Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.